Clinical Trials Logo

Clinical Trial Summary

Antibiotics are one of the most commonly prescribed drugs in pediatric care all over the world. Over prescription of antibiotics is a major public health problem and the most important factor in the emergence of antibiotic resistance. It is important to study physicians' antibiotic prescribing behavior to understand its determinant and for further planning of appropriate interventions to optimize antibiotic prescription.


Clinical Trial Description

Antibiotics are one of the most commonly prescribed drugs in pediatric care all over the world. Over prescription of antibiotics is a major public health problem and the most important factor in the emergence of antibiotic resistance. In Egypt, a recent study conducted in El-Minya governorate to investigate antibiotic use in PHC centres and in governmental hospitals, revealed that physician prescriptions of antibiotics for ARIs were extremely high as 82% of pediatric visits for ARIs resulted in an antibiotic prescription. Most of these infections are caused by viruses and do not require antibiotic treatment. Numerous interventions to improve antibiotic prescribing practices have been reported from various countries with varying results. No single intervention appears to have superior efficacy, but combinations of interventions are typically more effective, and strategies that target health care professionals and/or patients (or parents of young children) have achieved success at reducing antibiotic prescriptions for ARIs. Despite the emergence of antibiotic resistance and international efforts to reduce antibiotic use, prescription still high and inappropriate. Children are a vulnerable group and inappropriate antibiotic prescription may affect their health and may contribute to development of many diseases as allergies beside emergence of antibiotic resistance. Also, most of acute respiratory infections in children are viral infections and they receive antibiotic for it. So,, it is important to study physicians' antibiotic prescribing behavior to understand its determinant and for further planning of appropriate interventions to optimize antibiotic prescription. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04127682
Study type Observational
Source Assiut University
Contact
Status Completed
Phase
Start date January 1, 2021
Completion date October 30, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04081792 - Optimal Antibiotics for Operated Diabetic Foot Infections N/A
Recruiting NCT05499481 - Short Against Long Antibiotic Therapy for Infected Orthopedic Sites Phase 3
Recruiting NCT05950984 - Medical Device (MD) Derived Pharmacokinetic (PK) Parameters for Vancomycin (MD-PK)
Completed NCT03199911 - Topical Antibiotic Prophylaxis for Eyelids Phase 4
Completed NCT05355571 - The Impact of Probiotic Supplementation on Antibiotic Induced Changes in Gastrointestinal Function and/or Faecal Microbiota Composition N/A
Recruiting NCT05699174 - PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation Phase 3
Not yet recruiting NCT06395454 - Usage of Procalcitonin to Reduce Antibiotics Duration in VAP in Neurosurgical ICU N/A
Completed NCT03087890 - Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria Phase 4
Completed NCT01254097 - Probiotics in Primary Care N/A
Recruiting NCT06018792 - Molecular Culture for the Diagnosis of Pediatric Sepsis
Completed NCT06030713 - Timing of Maternal Antibiotic Prophylaxis During a Cesarean Section and the Early Infant Gut Microbiome N/A
Active, not recruiting NCT05027893 - Complications After Lower Third Molar Surgery N/A
Not yet recruiting NCT03935828 - Effect of Topical Sinonasal Antibiotics Phase 2
Not yet recruiting NCT06383637 - Antibiotic Use and Resistance KAP Among Dental Interns
Enrolling by invitation NCT04707092 - Use of Preoperative and Postoperative Antimicrobial Treatment Phase 4
Recruiting NCT03932708 - Improving Antibiotic Use in Urgent Care Facilities N/A
Recruiting NCT04731025 - Local Antibiotics for Breast Implants Phase 3
Completed NCT04403334 - Postoperative Safety Outcomes of Intraoperative Intracameral Preservative-Free Moxifloxacin Versus Levofloxacin Phase 4
Completed NCT05742295 - Prevention of Cefoperazone-induced Coagulopathy Phase 4
Not yet recruiting NCT06250413 - Autoflor -Lyophilized Capsulated Autological FMT to Restore Gut Microbiome After Treatment With Antibiotics N/A